These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. In vitro activity of the new quinolone BAY y 3118 against anaerobic bacteria. Nord CE, Lindmark A, Persson I. Eur J Clin Microbiol Infect Dis; 1993 Aug; 12(8):640-2. PubMed ID: 8223667 [Abstract] [Full Text] [Related]
9. In vitro activity of Bay 12-8039, a new 8-methoxyquinolone. Fass RJ. Antimicrob Agents Chemother; 1997 Aug; 41(8):1818-24. PubMed ID: 9257770 [Abstract] [Full Text] [Related]
10. The in-vitro activity of trovafloxacin and nine other antimicrobials against 413 anaerobic bacteria. Bowker KE, Wootton M, Holt HA, Reeves DS, MacGowan AP. J Antimicrob Chemother; 1996 Aug; 38(2):271-81. PubMed ID: 8877542 [Abstract] [Full Text] [Related]
16. Pharmacodynamic properties of BAY 12-8039 on gram-positive and gram-negative organisms as demonstrated by studies of time-kill kinetics and postantibiotic effect. Boswell FJ, Andrews JM, Wise R. Antimicrob Agents Chemother; 1997 Jun; 41(6):1377-9. PubMed ID: 9174203 [Abstract] [Full Text] [Related]
17. In-vitro activity of temafloxacin against anaerobic bacteria: a comparative study. Finegold SM, Molitoris E, Reeves D, Wexler HM. J Antimicrob Chemother; 1991 Dec; 28 Suppl C():25-30. PubMed ID: 1664827 [Abstract] [Full Text] [Related]